Infectious Progeny of 2009 A (H1N1) influenza virus replicated in and released from human neutrophils

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Zhang, Zhang ^a   Huang, Tao ^a   Yu, Feiyuan ^a   Liu, Xingmu ^a   Zhao, Conghui ^b   Chen, Xueling ^a   Kelvin, David J ^a,c,d,e   Gu, Jiang ^a,b  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF SASSARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; MESSENGER RNA; SIALIC ACID RECEPTOR; VIRAL PROTEIN;

ADULT; ANIMAL; CELL SEPARATION; CHICK EMBRYO; COCULTURE; GENETICS; HUMAN; INFLUENZA A VIRUS (H1N1); METABOLISM; NEUTROPHIL; PATHOGENICITY; PHYSIOLOGY; VIRION; VIROLOGY; VIRUS ENTRY; VIRUS REPLICATION;

ADULT; ANIMALS; CELL SEPARATION; CHICK EMBRYO; COCULTURE TECHNIQUES; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; NEUTROPHILS; RECEPTORS, CELL SURFACE; RNA, MESSENGER; VIRAL PROTEINS; VIRION; VIRUS INTERNALIZATION; VIRUS REPLICATION;

EID: 84949552722     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep17809     Document Type: Article

References (55)

1. Bale, J. F., Jr., O'Neil, M. E. & Greiner, T. The interaction of murine cytomegalovirus with murine neutrophils: effect on migratory and phagocytic activities. Journal of leukocyte biology 38, 723-734 (1985).
2. Szanton, E. & Sarov, I. Interaction between polymorphonuclear leukocytes and varicella-zoster virus-infected cells. Intervirology 24, 119-124 (1985).
3. Blackmon, J. R. & Ginsberg, H. S. Reactions of influenza viruses with Guinea pig polymorphonuclear leucocytes. I. Virus-cell interactions. Virology 2, 618-636 (1956).
4. Abramson, J. S. et al. Suppression of endocytosis in neutrophils by influenza A virus in vitro. The Journal of infectious diseases 154, 456-463 (1986).
5. Colamussi, M. L., White, M. R., Crouch, E. & Hartshorn, K. L. Influenza A virus accelerates neutrophil apoptosis and markedly potentiates apoptotic effects of bacteria. Blood 93, 2395-2403 (1999).
6. Daigneault, D. E. et al. Influenza A virus binding to human neutrophils and cross-linking requirements for activation. Blood 80, 3227-3234 (1992).
7. Ivan, F. X. et al. Neutrophils infected with highly virulent influenza H3N2 virus exhibit augmented early cell death and rapid induction of type I interferon signaling pathways. Genomics 101, 101-112, doi: 10.1016/j.ygeno.2012.11.008 (2013).
8. Wang, J. P. et al. Toll-like receptor-mediated activation of neutrophils by influenza A virus. Blood 112, 2028-2034, doi: 10.1182/blood-2008-01-132860 (2008).
9. Hufford, M. M. et al. Influenza-infected neutrophils within the infected lungs act as antigen presenting cells for anti-viral CD8(+ ) T cells. PloS one 7, e46581, doi: 10.1371/Journal.pone.0046581 (2012).
10. Zhao, Y. et al. Neutrophils may be a vehicle for viral replication and dissemination in human H5N1 avian influenza. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 47, 1575-1578, doi: 10.1086/593196 (2008).
11. Granelli-Piperno, A., Vassalli, J. D. & Reich, E. Rna and protein synthesis in human peripheral blood polymorphonuclear leukocytes. The Journal of experimental medicine 149, 284-289 (1979).
12. Bainton, D. F., Ullyot, J. L. & Farquhar, M. G. The development of neutrophilic polymorphonuclear leukocytes in human bone marrow. The Journal of experimental medicine 134, 907-934 (1971).
13. Cassidy, L. F., Lyles, D. S. & Abramson, J. S. Synthesis of viral proteins in polymorphonuclear leukocytes infected with influenza A virus. Journal of clinical microbiology 26, 1267-1270 (1988).
14. Jack, R. M. & Fearon, D. T. Selective synthesis of mRna and proteins by human peripheral blood neutrophils. Journal of immunology 140, 4286-4293 (1988).
15. Cline, M. J. Ribonucleic acid biosynthesis in human leukocytes. Effects of phagocytosis on Rna metabolism. Blood 28, 188-200 (1966).
16. Cline, M. J. Ribonucleic acid biosynthesis in human leukocytes: the fate of rapidly labeled Rna in normal and abnormal leukocytes. Blood 28, 650-664 (1966).
17. Tiku, K., Tiku, M. L. & Skosey, J. L. Interleukin 1 production by human polymorphonuclear neutrophils. Journal of immunology 136, 3677-3685 (1986).
18. Herz, C., Stavnezer, E., Krug, R. & Gurney, T., Jr. Influenza virus, an Rna virus, synthesizes its messenger Rna in the nucleus of infected cells. Cell 26, 391-400 (1981).
19. Samji, T. Influenza A: understanding the viral life cycle. The Yale Journal of biology and medicine 82, 153-159 (2009).
20. Weis, W. et al. Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature 333, 426-431, doi: 10.1038/333426a0 (1988).
21. Stray, S. J., Cummings, R. D. & Air, G. M. Influenza virus infection of desialylated cells. Glycobiology 10, 649-658 (2000).
22. Suzuki, T. et al. Sulphatide binds to human and animal influenza A viruses, and inhibits the viral infection. The Biochemical Journal 318 (Pt 2), 389-393 (1996).
23. Mercer, J. & Helenius, A. Gulping rather than sipping: macropinocytosis as a way of virus entry. Current opinion in microbiology 15, 490-499, doi: 10.1016/j.mib.2012.05.016 (2012).
24. Papayannopoulos, V. & Zychlinsky, A. NETs: a new strategy for using old weapons. Trends in immunology 30, 513-521, doi: 10.1016/j.it.2009.07.011 (2009).
25. Gu, J. et al. H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet 370, 1137-1145, doi: 10.1016/S0140-6736(07)61515-3 (2007).
26. Nicholls, J. M. et al. Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nature medicine 13, 147-149, doi: 10.1038/nm1529 (2007).
27. Kilbourne, E. D. in Influenza 255-289 (Springer, 1987).
28. Hartshorn, K. L. et al. Effects of influenza A virus on human neutrophil calcium metabolism. Journal of immunology 141, 1295-1301 (1988).
29. Jakab, G. J. & Green, G. M. Defect in intracellular killing of Staphylococcus aureus within alveolar macrophages in Sendai virusinfected murine lungs. The Journal of clinical investigation 57, 1533-1539, doi: 10.1172/JCI108423 (1976).
30. Gallin, J. I. & Snyderman, R. Inflammation: Basic Principles and Clinical Correlates. (Lippincott Williams & Wilkins, 1999).
31. Hartshorn, K. L., Collamer, M., White, M. R., Schwartz, J. H. & Tauber, A. I. Characterization of influenza A virus activation of the human neutrophil. Blood 75, 218-226 (1990).
32. Hartshorn, K. L. et al. Neutrophil deactivation by influenza A virus. Role of hemagglutinin binding to specific sialic acid-bearing cellular proteins. Journal of immunology 154, 3952-3960 (1995).
33. Stadlmann, J., Pabst, M. & Altmann, F. Analytical and Functional Aspects of Antibody Sialylation. Journal of clinical immunology 30 Suppl 1, S15-19, doi: 10.1007/s10875-010-9409-2 (2010).
34. Novel Swine-Origin Influenza, A. V. I. T. et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. The New England Journal of medicine 360, 2605-2615, doi: 10.1056/NEJMoa0903810 (2009).
35. Centers for Disease, C. & Prevention. Neurologic complications associated with novel influenza A (H1N1) virus infection in children-Dallas, Texas, May 2009. MMWR. Morbidity and mortality weekly report 58, 773-778 (2009).
36. Soto-Abraham, M. V. et al. Pathological changes associated with the 2009 H1N1 virus. The New England Journal of medicine 361, 2001-2003, doi: 10.1056/NEJMc0907171 (2009).
37. Peiris, J. S. et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 363, 617-619, doi: 10.1016/S0140-6736(04)15595-5 (2004).
38. Ungchusak, K. et al. Probable person-to-person transmission of avian influenza A (H5N1). The New England Journal of medicine 352, 333-340, doi: 10.1056/NEJMoa044021 (2005).
39. To, K. F. et al. Pathology of fatal human infection associated with avian influenza A H5N1 virus. Journal of medical virology 63, 242-246 (2001).
40. Uiprasertkul, M. et al. Apoptosis and pathogenesis of avian influenza A (H5N1) virus in humans. Emerging infectious diseases 13, 708-712, doi: 10.3201/eid1305.060572 (2007).
41. Maines, T. R. et al. Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science 325, 484-487, doi: 10.1126/science.1177238 (2009).
42. Osterlund, P. et al. Pandemic H1N1 2009 influenza A virus induces weak cytokine responses in human macrophages and dendritic cells and is highly sensitive to the antiviral actions of interferons. Journal of virology 84, 1414-1422, doi: 10.1128/JVI.01619-09 (2010).
43. Organization, W. H. Clinical management of human infection with pandemic (H1N1) 2009: revised guidance. World Health Organization Web site. http://www. who. int/csr/resources/publications/swineflu/clinical-management-h1n1. pdf. Accessed November (2009).
44. Patel, M., Dennis, A., Flutter, C. & Khan, Z. Pandemic (H1N1) 2009 influenza. British Journal of anaesthesia 104, 128-142, doi: 10.1093/bja/aep375 (2010).
45. Dominguez-Cherit, G. et al. Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA: the Journal of the American Medical Association 302, 1880-1887, doi: 10.1001/jama.2009.1536 (2009).
46. Coligan, J. E. V. (loose leaf) (John Wiley and Sons, New York).
47. Suzuki, Y. Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses. Biological & pharmaceutical bulletin 28, 399-408 (2005).
48. Stevens, J. et al. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 312, 404-410, doi: 10.1126/science.1124513 (2006).
49. Rogers, G. N. et al. Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity. Nature 304, 76-78 (1983).
50. Skehel, J. J. & Wiley, D. C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annual review of biochemistry 69, 531-569, doi: 10.1146/annurev.biochem.69.1.531 (2000).
51. Coico, R. V. (loose-leaf) (Wiley, Hoboken, N.J., 2006).
52. Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408, doi: 10.1006/meth.2001.1262 (2001).
53. Jiang, C. et al. Immunoglobulin G expression in lung cancer and its effects on metastasis. PloS one 9, e97359, doi: 10.1371/Journal.pone.0097359 (2014).
54. Song, Y. et al. Human surfactant protein A2 gene mutations impair dimmer/trimer assembly leading to deficiency in protein sialylation and secretion. PloS one 7, e46559, doi: 10.1371/Journal.pone.0046559 (2012).
55. Gu, J. et al. Fab fragment glycosylated IgG may play a central role in placental immune evasion. Human reproduction 30, 380-391, doi: 10.1093/humrep/deu323 (2015).